{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:00:07Z","timestamp":1769277607929,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.exppara.2009.02.001","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T23:33:20Z","timestamp":1234913600000},"page":"145-154","source":"Crossref","is-referenced-by-count":38,"title":["Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB\/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-\u03b3 to IL-10 ratio"],"prefix":"10.1016","volume":"122","author":[{"given":"Arun Kumar","family":"Haldar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subha","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kshudiram","family":"Naskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diganta","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashreen S.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syamal","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2009.02.001_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1369-5274(02)00286-2","article-title":"Phagosome of one\u2019s own: a microbial guide to life in the macrophage","volume":"5","author":"Amer","year":"2002","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.exppara.2009.02.001_bib2","doi-asserted-by":"crossref","first-page":"12968","DOI":"10.1074\/jbc.272.20.12968","article-title":"Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds","volume":"272","author":"Barbeau","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib3","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib4","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","article-title":"Hybrid cell vaccination resolves Leishmania donovani infection by eliciting strong CD8+CTL response with concomitant suppression of IL-10 but not IL-4 and IL-13","volume":"75","author":"Basu","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2009.02.001_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2009.02.001_bib6","first-page":"E60","article-title":"In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency","volume":"268","author":"Bevan","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.exppara.2009.02.001_bib7","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1016\/S0021-9258(17)40978-1","article-title":"Vanadate is a potent (Na, K)-ATPase inhibitor found in ATP derived from muscle","volume":"252","author":"Cantley","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jac\/43.3.359","article-title":"Indolylquinoline derivatives are cytotoxic to Leishmania donovani promastigotes and amastigotes in vitro and are effective in treating murine visceral leishmaniasis","volume":"43","author":"Chakrabarti","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2009.02.001_bib9","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.175.5.3214","article-title":"Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts","volume":"175","author":"Chakraborty","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends. Parasitol."},{"key":"10.1016\/j.exppara.2009.02.001_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.exppara.2009.02.001_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2249.2000.01270.x","article-title":"Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive V\u03b2-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes","volume":"121","author":"Davison","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0167-4838(86)90308-0","article-title":"Bromoperoxidase from Ascophyllum nodosum: a novel class of enzymes containing vanadium as a prosthetic group","volume":"869","author":"de Boer","year":"1986","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.exppara.2009.02.001_bib14","first-page":"148","article-title":"In vitro effects of vanadate on human immune functions","volume":"32","author":"Di Gioacchino","year":"2002","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.exppara.2009.02.001_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1040-8428(01)00221-9","article-title":"Vanadium in cancer treatment","volume":"42","author":"Evangelou","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.exppara.2009.02.001_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","article-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis","volume":"41","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2009.02.001_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"Ghalib","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exppara.2009.02.001_bib18","doi-asserted-by":"crossref","first-page":"22397","DOI":"10.1074\/jbc.M010828200","article-title":"Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide","volume":"276","author":"Huang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1165\/ajrcmb.23.1.3989","article-title":"Vanadium-induced kB-dependent transcription depends upon peroxide-induced activation of the p38 mitogen-activated protein kinase","volume":"23","author":"Jaspers","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.exppara.2009.02.001_bib20","first-page":"389","article-title":"Drug unresponsiveness & combination therapy for kala-azar","volume":"123","author":"Jha","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.exppara.2009.02.001_bib21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/mol.59.5.1147","article-title":"Activation of phosphatidylinositol 3-kinase and Akt by tert-butylhydroquinone is responsible for antioxidant response element-mediated rGSTA2 induction in H4IIE cells","volume":"59","author":"Kang","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.exppara.2009.02.001_bib22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exppara.2009.02.001_bib23","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib24","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/1521-4141(200009)30:9<2555::AID-IMMU2555>3.0.CO;2-X","article-title":"Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide","volume":"30","author":"Matte","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib25","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1128\/AAC.01196-07","article-title":"Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection","volume":"52","author":"Mookerjee Basu","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2009.02.001_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0006-2952(94)90014-0","article-title":"Antileishmanial activity and modification of hepatic xenobiotic metabolizing enzymes in golden hamster by 2(3)-tert-butyl-4-hydroxyanisole following infection with Leishmania donovani","volume":"47","author":"Mukhopadhyay","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2009.02.001_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/infdis\/157.5.973","article-title":"Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony","volume":"157","author":"Murray","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2009.02.001_bib29","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1074\/jbc.273.22.13944","article-title":"Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression","volume":"273","author":"Olivier","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0169-4758(93)90135-3","article-title":"Mechanisms of drug resistance in Leishmania","volume":"9","author":"Ouellette","year":"1993","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.exppara.2009.02.001_bib31","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.4049\/jimmunol.167.6.3391","article-title":"Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines","volume":"167","author":"Pathak","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AAC.45.2.439-446.2001","article-title":"High-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin","volume":"45","author":"P\u00e9rez-Victoria","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2009.02.001_bib33","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/S0021-9258(17)41818-7","article-title":"Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors, which are insulin mimetics","volume":"269","author":"Posner","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0304-4165(98)00038-5","article-title":"Diperoxovanadate participates in peroxidation reactions of H2O2 in presence of abundant catalase","volume":"1381","author":"Rao","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exppara.2009.02.001_bib35","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1021\/ic00095a023","article-title":"Oxygen-exchange reactions accompanying oxidation of vanadyl sulfate by diperoxovanadate","volume":"33","author":"Ravishankar","year":"1994","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/abbi.1995.1043","article-title":"Requirement of a diperoxovanadate-derived intermediate for the interdependent oxidation of vanadyl and NADH","volume":"316","author":"Ravishankar","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.exppara.2009.02.001_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0010-8545(98)00194-5","article-title":"The coordination chemistry of vanadium as related to its biological functions","volume":"182","author":"Rehder","year":"1999","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.exppara.2009.02.001_bib38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.2470147","article-title":"Murine MHC polymorphism and T cell specificities","volume":"244","author":"Roy","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.exppara.2009.02.001_bib39","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/515284","article-title":"Naive human T cells develop into Th1 or Th0 effectors and exhibit cytotoxicity early after stimulation with Leishmania-infected macrophages","volume":"177","author":"Russo","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2009.02.001_bib40","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","article-title":"IL-10- and TGF-\u03b2-mediated susceptibility in kala-azar and post-kala-azar dermal Leishmaniasis: the significance of Amphotericin B in the control of Leishmania donovani infection in India","volume":"179","author":"Saha","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1016160500979","article-title":"Peroxo-bridged divanadate as selective bromide oxidant in bromoperoxidation","volume":"236","author":"Sarmah","year":"2002","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.exppara.2009.02.001_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0277-5387(01)01005-1","article-title":"Reaction of diperoxovanadate with vanadyl sulphate in presence of EDTA as an access to dinuclear peroxovanadates(V)","volume":"21","author":"Sarmah","year":"2002","journal-title":"Polyhedron"},{"key":"10.1016\/j.exppara.2009.02.001_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.poly.2003.11.060","article-title":"Synthesis of new dinuclear and mononuclear peroxovanadium(V) complexes containing biogenic co-ligands: a comparative study of some of their properties","volume":"23","author":"Sarmah","year":"2004","journal-title":"Polyhedron"},{"key":"10.1016\/j.exppara.2009.02.001_bib44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1128\/br.39.2.121-143.1975","article-title":"Suppression of the immune response by microorganisms. American society for microbiology","volume":"39","author":"Schwab","year":"1975","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.exppara.2009.02.001_bib45","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantum induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"Silvestre","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1749-6632.1963.tb40679.x","article-title":"Immunity to Leishmaniasis","volume":"113","author":"Stauber","year":"1963","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exppara.2009.02.001_bib47","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection 1","volume":"175","author":"Stober","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.exppara.2009.02.001_bib48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral Miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exppara.2009.02.001_bib49","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/cr980427c","article-title":"Vanadium compounds as insulin mimics","volume":"99","author":"Thompson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.exppara.2009.02.001_bib50","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1039\/b002753g","article-title":"Design of vanadium compounds as insulin enhancing agents","volume":"17","author":"Thompson","year":"2000","journal-title":"J. Chem. Soc., Dalton Trans."},{"key":"10.1016\/j.exppara.2009.02.001_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1043-2760(96)00262-7","article-title":"Vanadium compounds: biological actions and potential as pharmacological agents","volume":"8","author":"Tsiani","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.exppara.2009.02.001_bib52","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.270.33.19383","article-title":"P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site","volume":"270","author":"Urbatsch","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib53","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1016\/S0020-1693(00)85548-6","article-title":"51V NMR investigation of a vanadate(V)-dependent peroxidase from Ascophyllum nodosum (L.) Le Jol","volume":"136","author":"Vilter","year":"1987","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.exppara.2009.02.001_bib54","first-page":"219","article-title":"Vitamin B12 and protein biosynthesis; VI. Reaction of vitamin B12 to amino acid activation","volume":"233","author":"Wagle","year":"1958","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exppara.2009.02.001_bib55","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0090-9556(24)15095-7","article-title":"In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein","volume":"28","author":"Wang","year":"2000","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.exppara.2009.02.001_bib56","unstructured":"World Health Organization (WHO). 2005. Magnitude of the problem. Available: http:\/\/www.who.int\/leishmaniasis\/burden\/magnitude\/burden_magnitude\/en\/index.html."},{"key":"10.1016\/j.exppara.2009.02.001_bib57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/B:MCBI.0000007278.27936.8b","article-title":"Vanadate activated Akt and promoted S phase entry","volume":"255","author":"Zhang","year":"2004","journal-title":"Mol. Cell. Biochem."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489409000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489409000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:46:11Z","timestamp":1738957571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489409000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0014489409000332"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2009.02.001","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}